MITRAL Trial Valve-in-Valve Arm 1-Year Outcomes

Summary taken directly from the American College of CardiologyWritten by: Debabrata Mukherjee, MD, FACC Quick Takes Transseptal MViV in selected patients at high surgical risk…

View More MITRAL Trial Valve-in-Valve Arm 1-Year Outcomes

Beyond Diabetes: The Impact of Empagliflozin in Heart Failure with Reduced Ejection Fraction

(Taken from Expert Analysis- ACC) This secondary analysis from the EMPEROR-Reduced trial shows that use of empagliflozin reduces the risk of CV death or HF…

View More Beyond Diabetes: The Impact of Empagliflozin in Heart Failure with Reduced Ejection Fraction